P-059: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED PHASE 3 RESOLVE TRIAL INVESTIGATING THE EFFICACY OF VOXELOTOR WITH STANDARD OF CARE IN THE RESOLUTION OF LEG ULCERS IN PATIENTS WITH SICKLE CELL DISEASE

P-059: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED PHASE 3 RESOLVE TRIAL INVESTIGATING THE EFFICACY OF VOXELOTOR WITH STANDARD OF CARE IN THE RESOLUTION OF LEG ULCERS IN PATIENTS WITH SICKLE CELL DISEASE

Bibliographic Details
Main Authors:	MINNITI C., BRADLEY S., DOSS J., PURDIE D., HOPPE C., CROUCH A.
Format:	Article
Language:	English
Published:	Wiley 2022-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000873128.79642.8d

Similar Items

5559749 A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
by: B. Andemariam, et al.
Published: (2023-04-01)

5579775 OVERVIEW OF THE VOXELOTOR POST-APPROVAL CLINICAL RESEARCH PROGRAM
by: C. Minniti, et al.
Published: (2023-04-01)

PB2516: ACTIGRAPHY IMPROVEMENT WITH VOXELOTOR (ACTIVE) STUDY: IMPACT OF VOXELOTOR ON PHYSICAL ACTIVITY, FATIGUE, AND SLEEP QUALITY
by: Nirmish Shah, et al.
Published: (2023-08-01)

Practical Guidance for the Use of Voxelotor in the Management of Sickle Cell Disease
by: Barriteau CM, et al.
Published: (2022-11-01)

P1432: PATTERNS OF VOXELOTOR USE IN A MULTICENTER, REAL-WORLD STUDY OF PATIENTS WITH SICKLE CELL DISEASE
by: Biree Andemariam, et al.
Published: (2023-08-01)

P1485: A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
by: B. Andemariam, et al.
Published: (2022-06-01)

P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES
by: Kadère Konté, et al.
Published: (2023-08-01)

Biophysical chemistry behind sickle cell anemia and the mechanism of voxelotor action
by: Mohd. Suhail
Published: (2024-01-01)

Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE‐KIDS 1 trial
by: Satheesh Chonat, et al.
Published: (2024-02-01)

Modeling the public health impact of voxelotor in the management of sickle cell disease in France.
by: Frédéric Galacteros, et al.
Published: (2023-01-01)

Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease
by: Paul Telfer, et al.
Published: (2018-05-01)

Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine
by: Michael Migotsky, et al.
Published: (2022-09-01)

5610417 IN-VITRO REAL-TIME OBSERVATION OF MODERATE SICKLING KINETICS IN SICKLE ERYTHROCYTES TREATED BY VOXELOTOR UNDER MONOTONIC AND CYCLIC HYPOXIA
by: Y.Q. Qiang, et al.
Published: (2023-04-01)

S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL
by: M Achebe, et al.
Published: (2022-01-01)

Sickle Cell Leg Ulcer Extending to the Achilles Tendon
by: Süheyl Asma, et al.
Published: (2023-03-01)

Lupus anticoagulant and leg ulcers in sickle cell anemia
by: Olayemi Edeghonghon, et al.
Published: (2009-01-01)

Leg ulcers in sickle cell patients: management challenges
by: El Khatib AM, et al.
Published: (2016-11-01)

Model‐informed drug development of voxelotor in sickle cell disease: Population pharmacokinetics in whole blood and plasma
by: Radojka M. Savic, et al.
Published: (2022-06-01)

Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease?
by: Syeda Tayyaba Rehan, et al.
Published: (2022-07-01)

Aspirin versus placebo for the treatment of venous leg ulcers—a phase II, pilot, randomised trial (AVURT)
by: Tilbrook Helen, et al.
Published: (2019-07-01)

Case report: leg ulcers resolving after discontinuation of clozapine for schizophrenia.
by: C Fragoeiro, et al.
Published: (2021-07-01)

S279: EFFECT OF VOXELOTOR ON CEREBRAL PERFUSION AND CEREBRAL OXYGEN METABOLISM IN ADULT PATIENTS WITH SICKLE CELL DISEASE; THE COVERAGE STUDY
by: Kadère Konté, et al.
Published: (2023-08-01)

REAL-WORLD DATA ON THE TREATMENT OF SICKLE CELL DISEASE WITH VOXELOTOR: RESULTS FROM A BRAZIL'S EARLY ACCESS PROGRAM
by: RD Cancado, et al.
Published: (2023-10-01)

Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease
by: Awni Alshurafa, et al.
Published: (2022-09-01)

The psychosocial impact of leg ulcers in patients with sickle cell disease: I don't want them to know my little secret.
by: Nkeiruka I Umeh, et al.
Published: (2017-01-01)

AVURT: aspirin versus placebo for the treatment of venous leg ulcers – a Phase II pilot randomised controlled trial
by: Helen Tilbrook, et al.
Published: (2018-10-01)

Low-level laser therapy of leg ulcer in sickle cell anemia
by: Claudia Regina Bonini-Domingos, et al.
Published: (2012-01-01)

NXY-059: brain or vessel protection.
by: Fisher, M, et al.
Published: (2006)

P-046: FACTORS ASSOCIATED WITH LEG ULCERS IN CAMEROONIAN SICKLE CELL DISEASE PATIENTS
by: EPOSSE C., et al.
Published: (2022-08-01)

More Unnecessary Imaginary Worlds – Part 4: The ICER Evidence Report for Crizanlizumab, Voxelotor and L-Glutamine for Sickle Cell Disease
by: Paul Langley
Published: (2020-05-01)

Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action
by: Michelle L. Green, et al.
Published: (2022-06-01)

Mini review: leg ulcers - a secondary complication of sickle cell disease
by: AlDallal SM
Published: (2019-08-01)

Haematological indices of sickle cell patients with chronic leg ulcers on compression therapy
by: Oluwatoyin A. Babalola, et al.
Published: (2020-12-01)

CGF treatment of leg ulcers: A randomized controlled trial
by: Amato Bruno, et al.
Published: (2019-12-01)

P-013: VOXELOTOR REDUCES SICKLE RED BLOOD CELL-MEDIATED HYPOXIC MICROVASCULAR OCCLUSION AS MEASURED BY OCCLUSIONCHIP IN VITRO MICROFLUIDIC ASSAY
by: SEKYONDA Z., et al.
Published: (2022-08-01)

Leg Ulcers in Sickle Cell Disease: A Multifactorial Analysis Highlights the Hemolytic Profile
by: Edvan do Carmo Santos, et al.
Published: (2023-02-01)

Sickle cell leg ulcer successfully managed by hyperbaric oxygen: a case report
by: Awni Alshurafa, et al.
Published: (2023-06-01)

Prevalence of people with sickle cell disease and leg ulcers in Brazil: Socioeconomic and clinical overview
by: Josimare Aparecida Otoni Spira, et al.
Published: (2022-01-01)

Prevalence of people with sickle cell disease and leg ulcers in Brazil: Socioeconomic and clinical overview.
by: Josimare Aparecida Otoni Spira, et al.
Published: (2022-01-01)

Efficacy and safety of pentoxifylline for chronic venous leg ulcers: study protocol for a multicenter randomized controlled trial in China (ESPECT study)
by: Lihong Chen, et al.
Published: (2023-08-01)